Netherlands vs Palestine, State of: Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage
Netherlands
88.0%
in 2024
Palestine, State of
87.0%
in 2024
Netherlands rank
75th
Palestine, State of rank
78th
Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage over time
- Netherlands
- Palestine, State of
How they compare
Netherlands currently reports 88.0% against 87.0% in Palestine, State of, a difference of 1.0%.
The two have swapped places 2 times across 13 shared years of data; in 2012 it was Netherlands ahead.
Netherlands ranks 75th and Palestine, State of ranks 78th of 146 countries.
Across the 2 decades both report, Netherlands averaged higher in 1 and Palestine, State of in 1.
Head to head by decade
| Decade | Netherlands | Palestine, State of | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 94.2% | 89.1% | 5.1% | Netherlands |
| 2020s | 90.4% | 93.2% | 2.8% | Palestine, State of |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage, Netherlands or Palestine, State of?
- Netherlands, at 88.0% against 87.0% in Palestine, State of as of 2024.
- What is the difference in pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage between Netherlands and Palestine, State of?
- 1.0%, with Netherlands ahead.
- How many years of comparable data are there for Netherlands and Palestine, State of?
- 13 years are reported by both, from 2012 to 2024.
- How do Netherlands and Palestine, State of rank globally for pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage?
- Netherlands ranks 75th and Palestine, State of ranks 78th of 146 countries.
- Where does this data come from?
- WHO & UNICEF (2025); UN, World Population Prospects (2024) – processed by Our World in Data, published as Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Share of one-year-olds who have had the third dose of the pneumococcal conjugate vaccine in a given year.